Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer

ConclusionsThese results demonstrated that CK2 activation was related to paclitaxel resistance and that CX-4945 in combination with paclitaxel could be used as a potential treatment for paclitaxel resistance in GC.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research